* Surgepays Inc SURG.OQ SURG.O is expected to show a
rise in
quarterly revenue when it reports results on May 11.
* The Bartlett Tennessee-based company is expected to
report a
72.7% increase in revenue to $36.503 million from $21.14 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Surgepays Inc is
for a
loss of 3 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 2,200.0% in the last three months.
* Wall Street's median 12-month price target for Surgepays
Inc is
$12.25, above its last closing price of $4.36.
This summary was machine generated May 10 at 02:05 GMT. All
figures in US dollars unless otherwise stated